Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease

Table 4 Association of axial disease activity, measured by the ASDAS and BASDAI scores, using the PsAID-12, using Spearman’s correlation coefficient

Domains PsAID	ASDAS CRP	ASDAS ESR	BASDAI
Pains	0.594***	0.540***	0.594***
Fatigue/Tiredness	0.599***	0.516***	0.664***
Skin Problems	0.529***	0.485***	0.537***
Work and/or leisure activity	0.548***	0.561***	0.573***
Physical Ability	0.488**	0.518***	0.483***
Discomfort	0.627***	0.627***	0.720***
Sleep disturbance	0.523***	0.512***	0.509***
Dealing with the disease	0.341*	0.369**	0.368**
Anxiety/Fear/Uncertainty	0.420**	0.378**	0.384**
Embarrassment and/or shame	0.339*	0.357**	0.406**
Social Participation	0.604***	0.620***	0.516***
Depression	0.458***	0.369**	0.410**
Total	0.671***	0.645***	0.683***

ASDAS-CRP Ankylosing Spondylitis Disease Activity Score – C Reactive Protein, ASDAS-ESR Ankylosing Spondylitis Disease Activity Score – Erythrocyte Sedimentation Rate, BASDAI Bath Ankylosing Spondylitis Disease Activity
*p < 0,05; **p < 0,01; ***p < 0,001

ISSN: 2523-3106